US Anticoagulation Therapy Market 2020 Global Trends, Statistics, Size, Share, Regional
Analysis By 2025-MRE Report
The US Anticoagulation Therapy Market is segmented on the lines of its product and regional.
Based on product segmentation it covers anticoagulation drugs and PT/INR testing devices.
Based on drug type, the anticoagulation therapy market for drugs is segmented into NOACs,
warfarin (VKA), and other drugs. In 2016, the NOACs segment dominated the US
anticoagulation therapy market for drugs. Due to the better safety and efficacy of NOACs as
compared to traditional therapies, the adoption of NOACs is higher as compared to traditional
drugs. US Anticoagulation Therapy Market on geographic segmentation covers various regions
such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each
geographic market is further segmented to provide market revenue for select countries such as
the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The US Anticoagulation Therapy Market is expected to exceed more than US$ 27.0 Billion by
2024 at a CAGR of 8% in the given forecast period.
You Can Browse Full Report Here: https://www.marketresearchengine.com/us-
The scope of the report includes a detailed study of global and regional markets for US
Anticoagulation Therapy Market with the reasons given for variations in the growth of the
industry in certain regions.
The growth within the anticoagulation medication market is primarily driven by the rising
incidence of blood vessel occlusion, arrhythmia, and stroke; long administration and high
volume of revenant sales of medical aid drugs; and increasing demand for novel oral
anticoagulants (NOACs). On the opposite hand, the high value of NOACs and demand of serious
investments within the development of anticoagulation medication are the key factors
restraining the expansion of this market. Additionally, the expansion within the anticoagulation
clinics market is primari